Joni Aldrich SOS: Supporter of Survival

CancerSOS: New Studies in Lung Cancer

July 16, 201451 min
Back-to-back interviews on exciting new studies in lung cancer! 1st Dr. Eric Haura, dir. Lung Comprehensive Research Center, H. Lee Moffitt Cancer Center, discusses precision medicine using oncogenic driver genes that physicians can use to determine the best targeted therapy for lung cancer treatment. 2nd Dr. Matthew Schabath, Dept. of Epidemiology, Moffitt, discusses a study to reduce the number of false findings on CT screening scans, improve scan accuracy and ultimately be more precise in identifying individuals at high risk for developing lung cancer. The findings from this study could be used to customize treatment to lung cancer patients. Joni live M-F at 2:00 p.m. ET on

Chat About CancerSOS: New Studies in Lung Cancer

For You